A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer

Opdivo (nivolumab) - Ono Pharma, BMS

VG161 - ViroGin Biotech

https://jitc.bmj.com/content/11/Suppl_1/A861

Yinan Shen1; Aijun Qin2; Yiting Qiu2; Xinyan Jin3; Wei Song4; Tian Fang3; Xingmei Liang3; Yuwei Li4; Qian Tan2; Ronghua Zhao5; Xueli Bai4; Tingbo Liang3

Sep 27, 2023